Skip to Main Content

Paper Details

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial.
medRxiv
5
2022
COVID, COVID-19, Fluvoxamine, SARS-CoV-2, coronavirus disease 2019, fluvoxamine, participant, participants, patients, women

Datasets